Sportradar Group AG (SRAD) Most Active Options

The 25 most actively traded Sportradar Group AG (SRAD) option contracts at the latest daily snapshot, ranked by volume. Each row shows the contract's price, implied volatility, delta, open interest, and how today's volume compares with its own 30-day average — click a contract to analyze it in the OptiView platform.

Data as of Aug 24, 2026, 3:55 PM ET · OPRA data 15 minutes delayed · For information only — not investment advice.

Last close
$13.15
52-week range
$12.25 – $31.78
ATM IV (30d)
45.6%
IV rank
33 / 100
Low
Expected move
±$1.57 (±11.9%)
Put/call OI
0.34
Call-heavy
Max pain
$12.5
↓ 4.9% below close

Most Active SRAD Contracts

ContractExpirationDTELastIV IV rank (30d)DeltaOpen interestVolumevs 30d avg
SRAD $15 call Oct 16, 2026 53d $0.40 52.0% 0 0.29 49 338 15.1× avg
SRAD $17.5 call Oct 16, 2026 53d $0.10 57.4% 6 0.12 0 200 8.9× avg
SRAD $15 call Nov 20, 2026 88d $0.82 52.7% 1 0.36 1,825 147 6.6× avg
SRAD $25 call Jan 21, 2028 515d $1.52 59.2% 41 0.31 173 95 11.8× avg
SRAD $15 call Jan 15, 2027 144d $1.25 53.9% 38 0.43 3,480 87 10.8× avg
SRAD $10 put Jan 21, 2028 515d $1.70 61.3% 56 -0.21 1,051 60 6.0× avg
SRAD $12.5 put Oct 16, 2026 53d $0.52 44.8% 57 -0.35 1 39 9.5× avg
SRAD $17.5 call Nov 20, 2026 88d $0.35 55.7% 4 0.19 1,155 34 1.5× avg
SRAD $15 call Sep 18, 2026 25d $0.15 47.3% 16 0.16 2,257 31 4.1× avg
SRAD $17.5 call Feb 19, 2027 179d $0.75 54.7% 38 0.30 413 27 3.4× avg
SRAD $10 put Dec 18, 2026 116d $0.37 61.0% 54 -0.16 20,579 18 1.8× avg
SRAD $15 call Dec 18, 2026 116d $1.05 57.0% 40 0.41 13,385 17 2.1× avg
SRAD $12.5 put Sep 18, 2026 25d $0.31 44.1% 36 -0.31 358 16 1.1× avg
SRAD $20 call Jan 15, 2027 144d $0.30 56.5% 39 0.17 4,458 14 1.7× avg
SRAD $17.5 call Dec 18, 2026 116d $0.50 58.5% 41 0.25 11,857 12 1.5× avg
SRAD $10 put Feb 19, 2027 179d $0.65 56.3% 32 -0.18 167 12 1.2× avg
SRAD $15 call Jan 21, 2028 515d $3.50 60.6% 42 0.60 433 11 1.4× avg
SRAD $17.5 put Jul 16, 2027 326d $5.50 56.0% 33 -0.59 1 10 32.5× avg
SRAD $5 call Oct 16, 2026 53d $8.20 207.6% 65 0.95 0 8 8.8× avg
SRAD $12.5 call Sep 18, 2026 25d $1.15 45.6% 0 0.68 1,074 7 0.0× avg
SRAD $12.5 call Dec 18, 2026 116d $1.90 57.0% 24 0.63 751 7 0.1× avg
SRAD $2.5 call Sep 18, 2026 25d $10.60 500.0% 100 0.97 0 6 28.3× avg
SRAD $12.5 call Jul 16, 2027 326d $3.30 59.1% 32 0.66 253 6 0.1× avg
SRAD $12.5 call Oct 16, 2026 53d $1.50 52.0% 2 0.64 0 5 0.1× avg
SRAD $12.5 put Nov 20, 2026 88d $1.00 52.2% 66 -0.36 326 4 1.0× avg

Ranked by volume at the latest daily snapshot. "vs 30d avg" compares today's volume with the contract's own 30-day average.

The most active SRAD contract today is the $15 call expiring in 53 days, with 338 contracts traded. Calls dominate the most-active list (18 of the top 25), showing where trading interest concentrates.

Explore the payoff profile of option on SRAD for free

Build multi-leg SRAD strategies, visualize payoffs, and scan the full US options universe with OptiView.

SRAD Options FAQ

Which SRAD option contract is most active today?

The most traded SRAD contract is the $15 call expiring Oct 16, 2026, with 338 contracts traded as of Aug 24, 2026.

How does OptiView rank the most active SRAD options?

The table lists the 25 SRAD contracts with the highest volume at the latest daily snapshot, alongside price, implied volatility, delta, open interest, and each contract's volume versus its own 30-day average.

Methodology. IV rank compares the current 30-day at-the-money implied volatility with its highest and lowest values over the past 52 weeks. Max pain is the strike that minimizes the total payout to option holders at expiration. The call and put walls are the strikes carrying the largest call and put open interest across all expirations. Net gamma exposure (GEX) is measured from the dealer perspective. All statistics are derived from delayed OPRA options data.

Options trading involves significant risk, and losses can exceed your initial investment. Always consult a licensed financial professional before making investment decisions. OptiView does not provide financial advice; all figures on this page are descriptive statistics, not recommendations.